Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.55
-0.50 (-7.09%)
Mar 31, 2025, 1:35 PM EDT - Market open
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $528.94 million as of March 31, 2025. Its market cap has decreased by -69.57% in one year.
Market Cap
528.94M
Enterprise Value
-173.78M
1-Year Change
-69.57%
Ranking
Category
Stock Price
$6.55
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $528.94M, an increase of 365.21%. That is a compound annual growth rate of 17.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 569.30M | -15.95% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |